SELLAS Life Sciences Group, Inc (SLS) Stock Price

1.73 ▲ +0.12 (+7.45%)
Open: 1.62 Vol: 150.96K Day's range: 1.60 - 1.73 Oct 01, 10:08 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
SLS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.71▲ 1.64▲ 1.62▲ 1.63▲ 1.75▼
MA10 1.69▲ 1.62▲ 1.61▲ 1.64▲ 1.74▼
MA20 1.65▲ 1.61▲ 1.61▲ 1.73▼ 1.77▼
MA50 1.62▲ 1.61▲ 1.65▲ 1.73▼ 1.44▲
MA100 1.61▲ 1.65▲ 1.69▲ 1.75▼ 1.29▲
MA200 1.61▲ 1.71▲ 1.78▼ 1.47▲ 2.07▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.009▲ 0.011▲ 0.010▲ -0.008▼ -0.033▼
RSI 75.332▲ 70.201▲ 64.936▲ 50.265▲ 51.973▲
STOCH 90.474▲ 59.213     52.959     26.087     44.275    
WILL %R -11.538▲ -10.000▲ -8.333▲ -56.579     -72.045    
CCI 96.801     262.458▲ 279.827▲ 5.309     -70.323    
Latest Filters Detected On SLS
▲ PSAR&MOM $SLS PSAR Switch Up + Momentum Set Alert
RSI $SLS RSI(14) Crossed Above 50 Set Alert
MA $SLS Price Crossed Above MA(13) Set Alert
MA $SLS Price Crossed Above MA(7) Set Alert
SELLAS Life Sciences Group, Inc News
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL ...
Tuesday, September 30, 2025 05:43 AM
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel ...
Tuesday, September 30, 2025 05:32 AM
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel ...
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds
Thursday, September 11, 2025 05:30 AM
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...
SLS historical stock data
date open high low close volume
01/10/25 1.62 1.73 1.60 1.715 875,772
30/09/25 1.56 1.67 1.56 1.61 2,085,768
29/09/25 1.61 1.63 1.55 1.56 3,211,344
26/09/25 1.61 1.67 1.57 1.63 1,437,743
25/09/25 1.63 1.66 1.585 1.61 1,625,199
24/09/25 1.71 1.765 1.61 1.63 3,958,693
23/09/25 1.75 1.75 1.70 1.70 1,621,374
22/09/25 1.65 1.75 1.615 1.72 3,464,986
19/09/25 1.60 1.66 1.60 1.63 2,648,800
18/09/25 1.70 1.7161 1.60 1.61 2,769,301
Quote Details
52wk Low:0.772
52wk High:2.269
Vol:150.96K
Avg Vol(3m):28.3M
1Y Chng:+37.20%
1M Chng:-7.30%
Add to Watch List
More Information
Index US Composite
Market Cap. 210.25M